NCT00003588View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

March 31, 2002

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

Ad5CMV-p53 gene

PROCEDURE

laparoscopic surgery

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003588 - Gene Therapy in Treating Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter